Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Molecular structure of the Staphylococcal antibiotic resistance protein AAC(6')-Ie/APH(2'')-Ia: structural analysis as a starting point in combating clinical resistance
FY 2012-13
Summary
Antibiotic resistance is one of the most serious problems affecting the future of medicine, in Canada and worldwide. Resistance exists for every antibiotic used in the clinic, and multiple drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) continue to spread through hospitals and the community. In order to stay ahead of the spread of resistance, it is essential to improve our understanding of the mechanisms of antibiotic resistance, and to use this understanding to combat and counteract resistance.
The aminoglycosides are one class of antibiotics commonly used to treat serious bacterial infections, but unfortunately widespread resistance limits their usefulness. Aminoglycoside resistance is primarily caused by enzymes that chemically modify the antibiotic. These enzymes are spread throughout pathogenic bacteria, including the "superbugs" MRSA and VRE. A particularly troublesome enzyme is AAC(6')/APH(2''), which inactivates almost every aminoglycoside. There is currently no effective way to inhibit this enzyme, and so bacteria that carry the enzyme cannot be treated with aminoglycosides at all. This project will address this problem by studying the molecular structure of AAC(6')/APH(2''). AAC(6')/APH(2'') is also unique, as it is bifunctional - two enzymes in one. Study of the molecular structure of the enzyme will give us a better understanding of the resistance caused by this enzyme.
I will examine the molecular structure of this enzyme using X-ray crystallography. By generating crystals of the purified enzyme, I will be able to use X-ray diffraction to construct an atomic model of the enzyme. From this atomic model, chemical compounds that can block or bypass the enzyme can be designed, which could restore effectiveness of aminoglycosides against bacteria carrying AAC(6')/APH(2''). These compounds could become useful anti-resistance drugs for use in the clinic.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283784
Name
Caldwell Shane J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular structure of the Staphylococcal antibiotic resistance protein AAC(6')-Ie/APH(2'')-Ia: structural analysis as a starting point in combating clinical resistance
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Antimicrobial Development; Biochemistry; Drug Design; Enzymology; Protein Crystallization; Protein Purification; Structural Biology; X-Ray Crystallography; X-Ray Scattering (Saxs)
Abstract
Antibiotic resistance is one of the most serious problems affecting the future of medicine, in Canada and worldwide. Resistance exists for every antibiotic used in the clinic, and multiple drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) continue to spread through hospitals and the community. In order to stay ahead of the spread of resistance, it is essential to improve our understanding of the mechanisms of antibiotic resistance, and to use this understanding to combat and counteract resistance.
The aminoglycosides are one class of antibiotics commonly used to treat serious bacterial infections, but unfortunately widespread resistance limits their usefulness. Aminoglycoside resistance is primarily caused by enzymes that chemically modify the antibiotic. These enzymes are spread throughout pathogenic bacteria, including the "superbugs" MRSA and VRE. A particularly troublesome enzyme is AAC(6')/APH(2''), which inactivates almost every aminoglycoside. There is currently no effective way to inhibit this enzyme, and so bacteria that carry the enzyme cannot be treated with aminoglycosides at all. This project will address this problem by studying the molecular structure of AAC(6')/APH(2''). AAC(6')/APH(2'') is also unique, as it is bifunctional - two enzymes in one. Study of the molecular structure of the enzyme will give us a better understanding of the resistance caused by this enzyme.
I will examine the molecular structure of this enzyme using X-ray crystallography. By generating crystals of the purified enzyme, I will be able to use X-ray diffraction to construct an atomic model of the enzyme. From this atomic model, chemical compounds that can block or bypass the enzyme can be designed, which could restore effectiveness of aminoglycosides against bacteria carrying AAC(6')/APH(2''). These compounds could become useful anti-resistance drugs for use in the clinic.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Caldwell, Shane J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~